Akebia Therapeutics
AKBA
#6958
Rank
NZ$0.68 B
Marketcap
$3.25
Share price
4.02%
Change (1 day)
110.24%
Change (1 year)

Akebia Therapeutics (AKBA) - Cash on Hand

Cash on Hand as of June 2024 : NZ$66.14 Million

According to Akebia Therapeutics's latest financial reports the company has NZ$66.14 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Akebia Therapeutics - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$67.87 M-52.36%
2022-12-31NZ$0.14 B-35.03%
2021-12-31NZ$0.21 B-41.11%
2020-12-31NZ$0.37 B69.81%
2019-12-31NZ$0.21 B-54.27%
2018-12-31NZ$0.47 B7.16%
2017-12-31NZ$0.44 B19.06%
2016-12-31NZ$0.37 B85.79%
2015-12-31NZ$0.20 B45.52%
2014-12-31NZ$0.13 B250.89%
2013-12-31NZ$39.61 M1885.99%
2012-12-31NZ$1.99 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$15.08 B 22,713.24%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$23.47 B 35,394.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$33.98 B 51,286.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.45 B 586.69%๐Ÿ‡บ๐Ÿ‡ธ USA